17-44075780-G-C
Variant summary
Our verdict is Pathogenic. The variant received 14 ACMG points: 14P and 0B. PM1PP3_StrongPP5_Very_Strong
The NM_138387.4(G6PC3):c.778G>C(p.Gly260Arg) variant causes a missense change. The variant allele was found at a frequency of 0.000114 in 1,612,074 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_138387.4 missense
Scores
Clinical Significance
Conservation
Publications
- autosomal recessive severe congenital neutropenia due to G6PC3 deficiencyInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 14 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_138387.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| G6PC3 | NM_138387.4 | MANE Select | c.778G>C | p.Gly260Arg | missense | Exon 6 of 6 | NP_612396.1 | ||
| G6PC3 | NM_001384165.1 | c.433G>C | p.Gly145Arg | missense | Exon 6 of 6 | NP_001371094.1 | |||
| G6PC3 | NM_001384166.1 | c.433G>C | p.Gly145Arg | missense | Exon 7 of 7 | NP_001371095.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| G6PC3 | ENST00000269097.9 | TSL:1 MANE Select | c.778G>C | p.Gly260Arg | missense | Exon 6 of 6 | ENSP00000269097.3 | ||
| G6PC3 | ENST00000588558.6 | TSL:1 | n.*753G>C | non_coding_transcript_exon | Exon 7 of 7 | ENSP00000467624.1 | |||
| G6PC3 | ENST00000588558.6 | TSL:1 | n.*753G>C | 3_prime_UTR | Exon 7 of 7 | ENSP00000467624.1 |
Frequencies
GnomAD3 genomes AF: 0.0000592 AC: 9AN: 152154Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000560 AC: 14AN: 249872 AF XY: 0.0000370 show subpopulations
GnomAD4 exome AF: 0.000120 AC: 175AN: 1459920Hom.: 0 Cov.: 33 AF XY: 0.000128 AC XY: 93AN XY: 726390 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000592 AC: 9AN: 152154Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74318 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Autosomal recessive severe congenital neutropenia due to G6PC3 deficiency Pathogenic:5Other:1
This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 260 of the G6PC3 protein (p.Gly260Arg). This variant is present in population databases (rs200478425, gnomAD 0.01%). This missense change has been observed in individuals with syndromic severe congenital neutropenia (PMID: 19118303, 20616219, 23180359, 23441086). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 30874). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt G6PC3 protein function with a positive predictive value of 95%. Experimental studies have shown that this missense change affects G6PC3 function (PMID: 25492228). For these reasons, this variant has been classified as Pathogenic.
The p.Gly260Arg variant substitutes the glycine at amino acid position 260 with an arginine. This variant has been observed in the homozygous state or in trans with a second pathogenic variant in multiple unrelated individuals with G6PC3 (MIM: 612541; PMID: 23758768, PMID: 23180359, PMID: 19118303, PMID: 22050868). The p.Gly260Arg variant is an ancient founder variant found primarily in individuals of European ancestry (14 of 129,040 alleles, gnomAD v2.1.1; PMID: 23758768). Functional studies have shown that the p.Gly260Arg variant lacks hydrolytic activity (PMID: 25492228, McDermott et al., PMID: 20616219).
Variant summary: G6PC3 c.778G>C (p.Gly260Arg) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 5.6e-05 in 249872 control chromosomes (gnomAD). This frequency is not significantly higher than estimated for a pathogenic variant in G6PC3 causing autosomal recessive severe congenital neutropenia due To G6PC3 deficiency, allowing no conclusion about variant significance. c.778G>C has been reported in the literature in multiple individuals (both homozygous and presumed compound heterozygous) affected with autosomal Recessive severe congenital neutropenia due To G6PC3 deficiency (Boztug_2012, Banka_2011). These data indicate that the variant is very likely to be associated with disease. The following publications have been ascertained in the context of this evaluation (PMID: 22050868, 21264919). ClinVar contains an entry for this variant (Variation ID: 30874). Based on the evidence outlined above, the variant was classified as pathogenic.
not provided Pathogenic:3
PP1, PP3, PM3_very_strong, PS3_moderate, PS4
Published functional studies demonstrate a damaging effect with no detectable enzyme activity (PMID: 25492228); Reported as a common pathogenic variant among individuals of European background (PMID: 23758768); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 23441086, 19118303, 19775295, 20220065, 20616219, 23180359, 25491320, 23758768, 25492228)
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at